Compare Paychex, Inc. (PAYX) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Paychex, Inc. vs Tempus AI — how do they compare? Paychex, Inc. trades at $114.91 (market cap $40.85B), while Tempus AI trades at $59.98 (market cap $11.13B). The key difference: Paychex, Inc. is far larger — about 3.7× Tempus AI's market cap, and Paychex, Inc. pays a 4.15% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| PAYX | TEM | |
|---|---|---|
Market Cap | $40.85B | $11.13B |
Sector | Industrials | Broad Market / Factor |
52-Week High | $135.46 | $103.25 |
52-Week Low | $85.57 | $41.55 |
Enterprise Value | $44.33B | $11.75B |
Dividend Yield | 4.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Paychex (PAYX) trades at $116.93, down 3.93% in the last session. The stock shows strong profitability with a net income margin of 27.03% and ROE of 44.77%. Recent earnings have consistently beaten expectations, with Q1 2026 EPS of $1.32 surpassing the $1.31 estimate. Technical indicators are mixed, with a bearish moving average signal but RSI suggesting potential oversold conditions. The company continues to expand its AI-driven WISE platform, enhancing service efficiency for small businesses.
The outlook for PAYX is cautiously optimistic, supported by robust cash flow and strategic AI integration. However, risks include elevated valuation multiples and competitive pressures in the HR solutions space. Analyst consensus is a 'Hold' with a $120 price target, indicating limited near-term upside from current levels amid balanced growth and risk factors.
Tempus AI (TEM) trades at $64.29, down 0.51% on the day, with a bullish technical signal from moving averages and RSI near oversold levels. The company reported a net loss of $245.03M in 2025 despite revenue of $1.27B, but recent quarterly EPS beats and FDA clearance for an AI-enabled ECG product (Business Wire, 2026-08-24) highlight growth potential in precision medicine. Analyst consensus is strongly bullish with a $69.20 price target.
Outlook: TEM's AI-driven healthcare platform positions it for long-term growth amid industry shifts toward personalized medicine, though persistent losses and high P/B of 25.01 pose valuation risks. Near-term catalysts include continued execution on recent contracts and pipeline developments, but investors face volatility from cash burn and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
